University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

The role of 5α‐reductase inhibitors in gastro‐oesophageal cancer risk : A nested case‐control study

dc.contributor.authorBusby, John
dc.contributor.authorKarasneh, Reema
dc.contributor.authorMurchie, Peter
dc.contributor.authorMcMenamin, Úna
dc.contributor.authorGadalla, Shahinaz M.
dc.contributor.authorCamargo, M. Constanza
dc.contributor.authorIversen, Lisa
dc.contributor.authorLee, Amanda J.
dc.contributor.authorSpence, Andrew D.
dc.contributor.authorCardwell, Chris R.
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Medical Statisticsen
dc.date.accessioned2020-11-12T00:07:15Z
dc.date.available2020-11-12T00:07:15Z
dc.date.embargoedUntil2020-11-12
dc.date.issued2020-01
dc.description.statusPeer revieweden
dc.format.extent9
dc.format.extent358678
dc.identifier147682256
dc.identifierdcf1515b-9b33-4521-909f-cdcedc11be11
dc.identifier000495812700001
dc.identifier31713940
dc.identifier85075021588
dc.identifier.citationBusby, J, Karasneh, R, Murchie, P, McMenamin, Ú, Gadalla, S M, Camargo, M C, Iversen, L, Lee, A J, Spence, A D & Cardwell, C R 2020, 'The role of 5α‐reductase inhibitors in gastro‐oesophageal cancer risk : A nested case‐control study', Pharmacoepidemiology and Drug Safety, vol. 29, no. 1, pp. 48-56. https://doi.org/10.1002/pds.4909en
dc.identifier.doi10.1002/pds.4909
dc.identifier.iss1en
dc.identifier.issn1053-8569
dc.identifier.otherORCID: /0000-0001-9968-5991/work/83704212
dc.identifier.otherORCID: /0000-0002-4865-9061/work/159078259
dc.identifier.urihttps://hdl.handle.net/2164/15355
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85075021588&partnerID=8YFLogxKen
dc.identifier.vol29en
dc.language.isoeng
dc.relation.ispartofPharmacoepidemiology and Drug Safetyen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectgastric canceren
dc.subjectoesophageal canceren
dc.subjectAndrogenen
dc.subject5α-reductase inhibitoren
dc.subjectANDROGEN RECEPTORen
dc.subjectandrogenen
dc.subjectADENOCARCINOMAen
dc.subjectFINASTERIDEen
dc.subjectBARRETTS-ESOPHAGUSen
dc.subject5 alpha-reductase inhibitoren
dc.subjectSEX-HORMONE RECEPTORSen
dc.subjectGASTRIC-CANCERen
dc.subjectCELL-MIGRATIONen
dc.subjectPROSTATE-CANCERen
dc.subjectESOPHAGEAL CANCERen
dc.subjectEXPRESSIONen
dc.subjectRC0254 Neoplasms. Tumors. Oncology (including Cancer)en
dc.subjectPharmacology (medical)en
dc.subjectEpidemiologyen
dc.subjectSupplementary Dataen
dc.subject.lccRC0254en
dc.titleThe role of 5α‐reductase inhibitors in gastro‐oesophageal cancer risk : A nested case‐control studyen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Busby_et_al_5ar_go_05_08_19_AAM.pdf
Size:
350.27 KB
Format:
Adobe Portable Document Format

Collections